Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Peter Savas
Based on 24 articles published since 2009
(Why 24 articles?)
||||
Expertise Level
The expertise of Peter Savas ranks in the
  • Top 0.21%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 24 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Savas, Peter   ·   Savas, P
Work Locations
Details
Most likely:    Peter MacCallum Cancer Centre      
2018
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Department of Pathology/GZA, Antwerp, Belgium. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Melbourne, VIC, Australia. · Pubmed 29808015
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group, Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Breast Center, Cantonal Hospital, St Gallen, Switzerland. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 29902286
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. · School of Medicine, Tsinghua University, Beijing, China. · Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery Royal Melbourne Hospital and Royal Womens' Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29942092
2017
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28947417
  • Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, 1000, Belgium. · Breast Cancer Research Program and Department of Medicine, Vanderbilt-Ingram Cancer Centre and Vanderbilt University Medical Centre, Nashville, TN, 37232, USA. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Pubmed 28928458
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
  • Department of Pathology, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Department of Pathology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Molecular Genomics Core, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Cancer Genomics Program, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Translational Breast Cancer Research, The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Department of Anatomical Pathology, South Eastern Area Pathology Service, St George Hospital, Kogarah, NSW, Australia. · School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. · Discipline of Pathology, School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Cancer Pathology, Bosch Institute, University of Sydney, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Camperdown, NSW, Australia. · School of Medicine and UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Australia. · Breast Service, The Royal Melbourne and Royal Women's Hospitals, Parkville, VIC, Australia. · Department of Surgery, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. · Pubmed 28338653
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 26755511
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
  • Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, Victoria 8006, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Institute of Pathology, Charité University Hospital, and German Cancer Consortium (DKTK), Charitéplatz 1, Berlin 10117, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia. · Pubmed 26667975
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium. · Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA. · Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Department of Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Pubmed 27672107
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pubmed 26300242
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
2014
  • Translational Breast Cancer Genomics Laboratory, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25290412
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25188474
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Probable:    University of Melbourne      
2018
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group, Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Breast Center, Cantonal Hospital, St Gallen, Switzerland. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 29902286
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. · School of Medicine, Tsinghua University, Beijing, China. · Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery Royal Melbourne Hospital and Royal Womens' Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29942092
2017
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
2015
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Probable:    Vanderbilt University   Contact    
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 24 total) written by Peter Savas about Breast Neoplasms:

  • Checkpoint blockade in the treatment of breast cancer: current status and future directions. 2018
  • Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial. 2018
  • Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2). 2018
  • Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. 2018
  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. 2017
  • Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study. 2017
  • Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer. 2017
  • Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer. 2017
  • Combined immune checkpoint blockade as a therapeutic strategy for 2017
  • Novel Targeted Agents and Immunotherapy in Breast Cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Peter Savas using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Peter MacCallum Cancer Centre
University of Melbourne
Vanderbilt University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Peter MacCallum Cancer Centre
2018
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Department of Pathology/GZA, Antwerp, Belgium. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Melbourne, VIC, Australia. · Pubmed 29808015
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group, Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Breast Center, Cantonal Hospital, St Gallen, Switzerland. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 29902286
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. · School of Medicine, Tsinghua University, Beijing, China. · Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery Royal Melbourne Hospital and Royal Womens' Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29942092
2017
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28947417
  • Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, 1000, Belgium. · Breast Cancer Research Program and Department of Medicine, Vanderbilt-Ingram Cancer Centre and Vanderbilt University Medical Centre, Nashville, TN, 37232, USA. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Pubmed 28928458
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
  • Department of Pathology, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Department of Pathology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Molecular Genomics Core, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Cancer Genomics Program, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Translational Breast Cancer Research, The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Department of Anatomical Pathology, South Eastern Area Pathology Service, St George Hospital, Kogarah, NSW, Australia. · School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. · Discipline of Pathology, School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Cancer Pathology, Bosch Institute, University of Sydney, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Camperdown, NSW, Australia. · School of Medicine and UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Australia. · Breast Service, The Royal Melbourne and Royal Women's Hospitals, Parkville, VIC, Australia. · Department of Surgery, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. · Pubmed 28338653
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 26755511
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
  • Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, Victoria 8006, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Institute of Pathology, Charité University Hospital, and German Cancer Consortium (DKTK), Charitéplatz 1, Berlin 10117, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia. · Pubmed 26667975
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium. · Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA. · Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Department of Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Pubmed 27672107
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pubmed 26300242
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
2014
  • Translational Breast Cancer Genomics Laboratory, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25290412
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25188474
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
University of Melbourne
2018
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group, Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Breast Center, Cantonal Hospital, St Gallen, Switzerland. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 29902286
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. · School of Medicine, Tsinghua University, Beijing, China. · Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery Royal Melbourne Hospital and Royal Womens' Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29942092
2017
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
2015
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Vanderbilt University
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Duke-NUS Medical School
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
Miscellaneous institutions in Melbourne
2017
  • Peter MacCallum Cancer Centre, Melbourne. · Latrobe Regional Hospital, Traralgon. · University of Melbourne, Melbourne, Australia. · Pubmed 28430863
73 Other Locations Show
Yearly article counts 04962300000